The tumor suppressor p53 and its target the CDK inhibitor p21 (Cip1/Waf1) are key components of the cellular response to DNA damage. Insight into how p21 is regulated in normal cells, and how it may be deregulated in tumor cells is important for the understanding of tumorigenesis. p21 was induced in normal human diploid ®broblasts after UV irradiationinduced DNA damage, but, at a high dose of UV irradiation, a faster mobility form of p21 on SDS ± PAGE (designated p21D) was expressed. Surprisingly, in a variety of growing transformed cell lines, the level of p21 was low but p21D was prominent. We found that p21D appeared to be derived through a loss of around 10 amino acids from the C-terminus of p21, which theoretically would remove the PCNA binding domain, a second cyclin binding domain and the nuclear localization signal sequence. Several characteristics distinguish p21 from p21D. Both the full length p21 and p21D could be stabilized by a proteasome inhibitor, but only the full length p21 was associated with Cdk2 and PCNA. Consistent with this, gel ®ltration chromatography revealed that all the full length p21 in the cell was complexed to other proteins, whereas a signi®cant portion of p21D was in monomeric form. Moreover, p21 was mainly localized to the nucleus, but p21D was mainly localized to the cytoplasm. We propose that the decrease in p21 and increase in p21D could contribute to the deregulation of the cell cycle, and could be a mechanism involved in cellular transformation.
Introduction
Cyclins and cyclin-dependent kinases (CDKs) are key regulators of the eukaryotic cell cycle (Murray and Hunt, 1993) . By de®nition, the activation of CDKs is dependent on the association with a cyclin subunit. CDKs are also regulated by phosphorylation; the activity of cyclin-CDK holoenzyme is increased by phosphorylation of Thr161 and inhibited by phosphorylation of Thr14 and Tyr15. Thr161 can be phosphorylated by the CDK-activating kinase (CAK) (Morgan, 1995) , and dephosphorylated by the CDKinteracting phosphatase KAP . The Wee1 protein kinase can phosphorylate Tyr15 of Cdc2 (Morgan, 1995) , and the membraneassociated Wee1-related kinase Myt1 can phosphorylate both Thr14 and Tyr15 (Mueller et al., 1995) . Both Thr14 and Tyr15 can be dephosphorylated by the members of the Cdc25 protein phosphatase family (Morgan, 1995) .
The activity of CDKs is negatively regulated by binding to protein inhibitors, which fall into two families based on sequence homology. One CDK inhibitor family includes p16 INK4A , p15 INK4B , p18
INK4C
, and p19
INK4D
. The p16
INK4A family is speci®c for cyclin D-CDK4/6 complexes (Sherr and Roberts, 1995) . A protein encoded by an alternative reading frame of INK4A, p19 ARF , is able to arrest the cell cycle, although there is no evidence that it acts as a direct CDK inhibitor (Quelle et al., 1995) . The other CDK inhibitor family includes p21(Cip1/Waf1), p27 Kip1 (Polyak et al., 1994; Toyoshima and Hunter, 1994) , and p57
Kip2 (Lee et al., 1995; Matsuoka et al., 1995) . The archetypal member of this family, p21, was isolated as a Cdk2-associated protein and an inhibitor of Cdk2 (Gu et al., 1993; Harper et al., 1993; Xiong et al., 1993a) , a gene induced by the tumor suppressor p53 (El-Deiry et al., 1993) and a gene whose RNA expression is increased in senescent cells (Noda et al., 1994) . In addition to being induced by p53, p21 is also induced by p53-independent pathways (Guo et al., 1995; Halevy et al., 1995; Jiang et al., 1994; Macleod et al., 1995; Michieli et al., 1994; Missero et al., 1995; Parker et al., 1995; Sheikh et al., 1994; Steinman et al., 1994; Zhang et al., 1995) . In contrast to the p16 INK4A family, p21 can bind and inhibit a wider spectrum of CDKs . Moreover, unlike the p16 INK4A family, which inhibits cyclin D-CDK by disrupting the complex (Hall et al., 1995) , p21 can form stable complexes with cyclin-CDK. The crystal structure of the cyclin A-Cdk2-p27
Kip1 complex shows that member of this p21 family contact both the cyclin and the CDK subunit in such complexes (Russo et al., 1996) . In addition to directly inhibiting the kinase activity of cyclin-CDK complexes, p21 also blocks the phosphorylation of the activating threonine residue in CDKs (Aprelikova et al., 1995) .
Residues *10 ± 80 of p21, p27 Kip1 and p57 Kip2 are related in sequence, and this region has been identi®ed as the cyclin and CDK-binding region (Chen et al., 1995; Goubin and Ducommun, 1995; Luo et al., 1995; Nakanishi et al., 1995) . Within this region, there are separate domains for binding to cyclin (residues 16 ± 24) (Adams et al., 1996; Ball et al., 1997; Chen et al., 1996; Zhu et al., 1995) and to CDK (residues 45 ± 65) (Ball et al., 1997; Goubin and Ducommun, 1995; Nakanishi et al., 1995) . A second cyclin-binding site on p21 has recently been identi®ed near the C terminus, which includes residues 152 ± 158 (Adams et al., 1996; Ball et al., 1997; Chen et al., 1996) . p21 can also associate with PCNA (Flores-Rozas et al., 1994) and inhibit DNA synthesis (Noda et al., 1994; Waga et al., 1994) but not DNA repair in vitro Shivji et al., 1994) . The PCNAbinding region (around amino acids 142 ± 164) lies at the very C-terminus of p21 (Chen et al., 1995; Goubin and Ducommun, 1995; Luo et al., 1995; Nakanishi et al., 1995; Warbrick et al., 1995) , as revealed by the crystal structure of a 22 residue peptide derived from the C-terminus of p21 in complex with PCNA (Gulbis et al., 1996) . The PCNA-binding site overlaps the nuclear localization signal (residues 140 ± 156) and the C-terminal cyclin-binding site. Either the N-tenninal CDK-or the PCNA-binding region of p21 is sucient to inhibit DNA replication when expressed in cells (Chen et al., 1995; Luo et al., 1995) .
The p53-p21 pathway is crucial for the arrest in cell cycle progression after DNA damage. When DNA is damaged, continued progression through the cell cycle is undesirable because this would lead to the accumulation of mutations. Two options adopted by damaged cells are either to halt cell cycle progression, or to eliminate themselves by apoptosis. Both cell cycle arrest (Kastan et al., 1991) and apoptosis (Clarke et al., 1993; Lotern and Sachs, 1993; Lowe et al., 1993) after ionizing irradiation are dependent on p53 function. The level and activity of p53 is increased following DNA damage; this in turn induces expression of p21, which may in part be responsible for cell cycle arrest. From the fact that about 50% of all human turnors are found to contain p53 mutations (Greenblatt et al., 1994) , it is likely that the failure to induce p21 in cells with mutant p53 could at least in part contribute to the mechanisms of tumorigenesis.
It is debatable whether the cell cycle arrest function, or the apoptotic function of p53 is more important in preventing genomic mutations. Mice that lack p21 develop normally without observable defects up to 7 months (Deng et al., 1995) , which is in marked contrast to mice that lack p53, which develop tumors spontaneously (Donehower et al., 1992) . Nonetheless, p21 7/7 embryonic ®broblasts are signi®cantly impaired in their ability to arrest in G1 following DNA damage by ionizing irradiation (Brugarolas et al., 1995; Deng et al., 1995; Waldman et al., 1995) , indicating that p21 is important, but not totally sucient for the DNA damage checkpoint. After DNA damage, the induced p21 is likely to be sucient to inhibit all cyclin-Cdk2 complexes, but only partially cyclin-Cdk4 and cyclinCdc2 complexes .
The p21 and p16 INK4A inhibitors were ®rst detected as 35 S-labeled proteins that coprecipitated with cyclins and CDKs from normal or transformed diploid human ®broblasts respectively (Xiong et al., 1992; Xiong et al., 1993b) . It was noted that the levels of CDK inhibitors (like p21) that associated with cyclin-CDK complexes is commonly altered in transformed cells, suggesting that changes in the abundance or the interactions of these inhibitors with cyclin-CDK complexes may contribute to the transformed state (Xiong et al., 1993b) . Here, we show that while relatively low dose of UV induced the expression of p21 in normal human diploid ®broblasts, a smaller form of p21 (designated p21D here) was induced when a relatively high dose of irradiation was used. Surprisingly, the majority of p21 in several transformed cell lines was in the p21D form. Extracts derived from normal cells treated with a high dose of UV or from transformed cells degrade exogenously added p21 faster than extracts derived from normal cells. p21D appeared to be generated by a loss of a small C-terminal fragment, and did not bind to either Cdk2 nor PCNA. We speculate that speci®c degradation and inactivation of p21 could lead to a failure to arrest progression through the cell cycle after DNA damage, and be a mechanism involved in cellular transformation.
Results
Novel form of p21 after high dose of UV irradiation and in transformed cells
During our studies on UV-induced DNA damage in AG1523 human normal diploid ®broblasts , we observed that both p53 and p21 were induced following UV irradiation (30 J/m 2 ). Intriguingly, at a higher dose of UV (60 J/m 2 ), p21 was not induced despite the increase in p53 level, but a *19 kDa form of p21 immunoreactive band (designated here as p21D) was observed. A similar pattern of induction of p21 at 30 J/m 2 , and appearance of p21D at 60 J/m 2 of UV irradiation was seen in other relatively normal cell types, like Swiss 3T3 mouse ®broblasts, NRK rat ®broblasts (unpublished observations), and KD) normal human diploid ®broblasts ( Figure 1a , lanes 1 ± 3) using other types of antibodies raised against full length human or mouse p21. In HUT12, a transformed cell line derived from normal KD cells by transformation with chemical carcinogens (Kakunaga, 1978) , p21 was also induced after UV-induced DNA damage (30 J/m 2 ) ( Figure 1A , lanes 4 and 5), indicating that HUT12 contains functional p53. However, we noticed that HUT12 contained higher amount of p21D than KD cells, both before and after irradiation treatment (see also Figure 1b ).
In the light of the above results, we then investigated the level of p21 and p21D in other human cancer cell lines ( Figure 1B) . As shown before, KD cells contained full length p21 which was induced after DNA damage (in this case with the chemotherapeutic drug adriamycin) (lanes 1 and 2). HUT12 cells contained full length p21, but p21D was also prominent (lane 3). Surprisingly, many other transformed human cell lines like HeLa cells (human cervical carcinoma cells), HaCaT cells (transformed human keratinocytes), 293 cells (transformed human embryonic kidney cells), HepG2 cells (human hepacellular carcinoma cells), and LAN5 cells (human neuroblastoma cells) all contained little full length p21, but instead the majority of p21 was in the p21D form, running at the same size on SDS ± PAGE as the p21D from normal ®broblasts irradiated with 60 J/m 2 UV. A few transformed cell lines like HaCaT and LAN5 contained relatively little p21 or p21D, and some cells such as HUT12 and K562 (human chronic myelogenous leukernia cells) do contained mainly full length p21. But even in these cells, the ratio of p21D to p21 was higher than that in normal cells. Unlike p21 and p21D, the level of a nonspeci®c higher molecular weight band that was recognized by the anti-p21 antibody did not vary signi®cantly (Figure 1b) , indicating that the appearance of p21D in transformed cells was probably not due to a general increase in protein degradation. Furthermore, we have not detected any correlated changes in the level of other cell cycle control proteins like cyclins and CDKs between normal and transformed cells (unpublished observations).
Both p21 and p21D are stabilized by a proteasome inhibitor
What is the identity of p21D? We found that both p21 and p21D were stabilized when proteasome activity was inhibited. In AG1523 cells, the level of full length p21 was increased dramatically by the proteasome inhibitor (Rock et al., 1994; Vinitsky et al., 1992) (Figure 2a) . In transformed cells, like 293 cells, the level of p21D was increased by LLnL. Moreover, some full length p21, which was not detectable in untreated 293 cells, was also detected after treatment with LLnL ( Figure 2a , seen more clearly in Figures 2b and 3 ). This suggests that full length p21 is probably made in transformed cells like 293, but is degraded rapidly in a proteasome-dependent manner. As a control we examined p53, the transcrip- p53 7/7 embryonic ®broblasts (lanes 1 and 2), AG1523 cells (lanes 3 and 4), and 293 cells (lanes 5 and 6) were either untreated (odd numbered lanes) or treated with LLnL, (even numbered lanes). Cell extracts were prepared and loaded (10 mg) onto SDS ± PAGE. The proteins were transferred to membrane and immunoblotted with anti-p21 (Cterminal peptide) antibody. (c) Degradation of recombinant p21 by cell extracts from UV-darnaged and transformed cells is more ecient than by extracts from normal cells. Recombinant p21 ± H6 was translated in a rabbit reticulocyte lysate in the presence of [ 2 ) (*), or HeLa cells (~) at a concentration of 5 mg/ml in a volume of 40 ml. The reactions were incubated at 378C and at the indicated times samples were taken and dissolved in SDS-sample buer. The samples (10 mg) were loaded onto SDS ± PAGE and the amount of 35 S in p21-H6 was quanti®ed with a Phosphorimager
Novel form of p21 Cip1/Waf1 tional activator of p21, which is degraded by the ubiquitin-proteasome pathway (Schener et al., 1990) , and found that p53 was also stabilized by LLnL in AG1523 cells (Figure 2a ). In contrast, untreated 293 cells contained a high concentration of p53, and its level was decreased by LLnL treatment. This dierence may be because 293 cells are transformed by adenovirus, and p53 is stabilized and functionally inactivated though its association with adenovirus E1B. Consistent with a lack of functional p53 in 293 cells we observed no induction of p21 or p21D after DNA damage (unpublished observations). To show that the increase in p21 in AG1523 cells was not merely due to an increase in the level of its transcriptional activator p53, we tested an embryonic ®broblast cell line derived from p53 7/7 knockout mice. LLnL also increased the level of p21 in p53 7/7 cells similar to that in AG1523 cells (Figure 2b ± an anti-p21 C-terminal peptide antibody was used here, which, as shown below, recognized the full length p21 but not p21D). Note that mouse p21 is smaller in size and migrated faster on SDS ± PAGE than human p21 (Huppi et al., 1994) . These data suggest that the degradation of both p21 and p21D involve proteasomes, but do not necessary rule out the possibility that p21D is derived from cleavage of p21.
If p21D was derived from proteolytic cleavage of full length p21, the relevant proteolytic activity should be higher in cells treated with high dose of UV and in some transformed cells. We next investigated whether the possible dierence in p21 degradation between normal and transformed cells could be recapitulated in vitro in cell extracts. C-terminal histidine-tagged human p21 (p21-H6) was translated in the presence of irradiated AG1523 and HeLa cell extracts degraded p21-H6 more eciently than normal AG1523 cell extracts. However, unlike the putative cleavage of p21 in cells, we did not observe any discrete faster migrating p21 band(s) under these in vitro assay conditions.
Dierential binding of p21 and p21D to Cdk2 and PCNA
We next investigated whether p21D was associated with Cdk2 and PCNA, the physiological partners of p21, in cell extracts. For this purpose, Cdk2 and PCNA were immunoprecipitated from extracts of 293 cells that were either untreated or treated with LLnL, and the immunoprecipitates were then immunoblotted with anti-p21 antibody. Figure 3 shows that only full length p21, but not p21D, was detected in association with Cdk2 and PCNA.
Dierential nucleus-cytoplasm localization of p21 and p21D
One possible explanation of why p21D did not bind Cdk2 and PCNA is that p21D and p21 may be located in dierent intracellular compartments in the cell. To test this possibility, 293 cell extracts were fractionated into nuclear and cytoplasmic fractions, and immunoblotted with anti-p21 antibodies (Figure 4a ). We found that full length p21 was present exclusively in the nuclear fraction, whereas p21D was in both the nuclear and cytoplasmic fractions, with a higher proportion in the cytoplasmic fraction. As a control, PCNA was found mainly in the nuclear fraction.
To investigate whether p21D was associated with other proteins, we fractionated 293 cell extracts by gel ®ltration chromatography. We did not observe a signi®cant amount of p21D in very high molecular size fractions (fraction 20 represented the¯ow- Figure 3 Binding of p21 and p21D to Cdk2 and PCNA. 293 cells were either untreated (lanes 1, 3 and 5) or treated with LLnL (lanes 2, 4, and 6). Cell extracts were prepared and immunoprecipitated (200 mg) with normal rabbit serum (NRS) (lanes 1 and 2), anti-Cdk2 (lanes 3 and 4) , or anti-PCNA antibody (lanes 5 and 6). The immunoprecipitates were dissolved in SDS-sample buer and loaded on SDS ± PAGE. The proteins were transferred to membrane and immunoblotted with anti-p21 (full length) antibody. Total cell extracts from 293 cells untreated (lane 7) or treated with LLnL (lane 8), and from AG1523 cells untreated (lane 9) or treated with LLnL (lane 10) were loaded for comparison (there was a slight mobility dierence in all proteins between the lanes with immunoprecipitates and the lanes with total extracts (i.e. between lanes 6 and 7), probably because of the large dierence in salt and protein concentration. Careful alignment with the help of Coomassie staining of the blot revealed that the bands in the immunoprecipitates corresponded to the full length p21 and not p21D through), suggesting p21D is not part of a large aggregate ( Figure 5 ). As will be shown later, the antip21 (full length) antibody recognized both the full length p21 and p21D ( Figure 5, top panel) , whereas the anti-p21 (C-terminal peptide) antibody recognized only full length p21 (middle panel). On the gel ®ltration column, full length p21 migrated only as a complexed form (about 150 kDa), but p21D migrated both as a complexed form (about 150 kDa) and an apparent monomeric form (about 30 kDa) ( Figure 5 , middle panel). We do not know what protein p21D was associated with in the 150 kDa peak, but the data from Figure 3 indicate that it was not Cdk2 or PCNA. Immunoblotting for PCNA across the same column was used for comparison (bottom panel). Taken together, these results suggest that, unlike full length p21, a signi®cant portion of p21D was found in the cytoplasm, and a signi®cant portion of p21D is not complexed to other proteins like Cdk2 and PCNA.
p21D lacks the C-terminal region
To get a better idea of how p21D is generated, we investigated whether p21D was recognized by an antibody raised against a peptide corresponding to the last 19 amino acids of p21. Figure 6a shows that an antibody raised against the full length p21 detected both p21 and p21D; in contrast, the anti-p21 (Cterminal peptide) antibody only detected p21 and not p21D. This suggests that p21D may lack the C-terminal region of p21. It is interesting that more than one band was detected in the region of full length p21 (especially apparent in 293 cells in Figure 6a) ; this is probably due to phosphorylation of p21 by the bound cyclin-CDK (unpublished observations).
A similar smaller version of p21 as p21D had been observed when Calu-1 cells and A549 cells were treated with the phorbol ester TPA (Tchou et al., 1996) . It is likely that the novel form of p21 observed by Tchou et al. corresponds to the p21D we describe here. Tchou et al. also found that the smaller form of p21 reacted with antibodies raised against the Nterminal peptide of p21, but not with antibodies raised against the C-terminal peptide of p21.
On SDS ± PAGE, p21D migrated at around 19 kDa. When compared with various recombinant C-terminal deletion mutants of p21 (Figure 6b ), p21D migrated between CD157 and CD150 (the number represents the C-terminal residue of the deleted protein; full length p21 contains 164 residues). This suggests that if p21D were indeed a C-terminally truncated version of p21, only *10 amino acids were cleaved o. Taken together, these results suggest that p21D is likely to be derived as Figure 5 Complex formation of p21 and p21D in cell extracts. Cell extracts from 293 cells (200 ml of 10 mg/ml) were fractionated by gel ®ltration chromatography using a Superose 12 HR10/30 column (Pharmacia) exactly as described . The fractions were subjected to SDS ± PAGE and immunoblotting with anti-p21 (full length) antibody (top panel), anti-p21 (C-terminal peptide) antibody (middle panel), or anti-PCNA antibody (bottom panel). The fraction numbers are shown at the bottom and the molecular mass standards for the gel ®ltration column are shown on the top a result of a small C-terminal truncation of p21, which theoretically would remove part of the bipartite nuclear localization signal sequence (residues 140 ± 156), PCNA binding region (residues 142 ± 164), and the C-terminal cyclin binding site (residues 152 ± 158) (see Figure 7a) .
Assuming that p21D is derived by proteolytic cleavage of the last 10 residues of p21, one might expect p21D to be unable to bind PCNA because the PCNA-binding domain of p21 is located at the very Cterminus, but it is not clear why p21D should not be able to bind to Cdk2, since the main cyclin A-Cdk2 binding region is in the N-terminal half of p21 (around residues 30 ± 70). As summarized in Figure 7a , a small deletion at the C-terminus of p21 (CD157) was sucient to prevent its binding to PCNA as expected from the location of the PCNA-binding region, but did not diminish the binding of p21D to cyclin-Cdk2 or inhibition of its histone H1 kinase activity in vitro. Since binding of p21 to cyclin A-Cdk2 inhibits the phosphorylation of Cdk2 by CAK, we also assessed p21 binding by this means, and the results were in perfect concordance with those obtained by direct binding and inhibition of H1 kinase activity (i.e. any mutant p21 that failed to bind did not inhibit CAK phosphorylation). Consistent with the in vitro data, overexpression of C-terminal deletion mutants of p21 like CD157 and CD150 in HeLa cells were able to cause cell cycle arrest with eciency similar to the full length p21 (Figure 7b ). But it should be noted that the expression level of p21 and mutants in these transient transfection experiments was at least 100 times higher than the endogenous p21 or p21D (data not shown). Thus at least when vastly overexpressed, p21 fragments similar size to p21D were still capable of arresting the cell cycle. But it is possible Figure 7 Overexpression of C-terminal deletion mutants of p21 can cause cell cycle arrest. (a) GST-fusion proteins of p21 and mutants were constructed as described in Materials and methods. A schematic diagram of p21 and its mutants is shown on the left. The two boxes represent the conserved regions in the p21, p27
Kip1 and p57 Kip2 family of CDK inhibitors. The mutants were deleted from the N-terminus (ND) or from the C-terminus (CD); the number following D indicates the amino acid residue that the mutant was deleted to. The right hand side summarizes the ability of these p21 mutants to bind to a complex of Cdk2 (reticulocyte lysateexpressed) and cyclin A-H6 (bacterially expressed), to inhibit cyclin A-H6-GST-Cdk2 complex histone H1 kinase activity, to block CAK phosphorylation of cyclin A-H6-Cdk2, or to bind puri®ed PCNA compared to full length GST-p21 (Materials and methods). that at physiological levels, C-terminal deletion mutants of p21 are not as good as full length p21 at binding cyclin-CDK and arresting the cell cycle.
Discussion
The tumor suppressor p53 and its target p21 are key components of the cellular response to DNA damage. Hence insights into how p21 is regulated in normal cells, and how it may be deregulated in tumor cells are important for our understanding of tumorigenesis. We show that in contrast to normal human diploid ®broblasts, which contained a relatively low level of p21 that could be further induced following DNA damage, many transformed human cell lines contained a *19 kDa form of p21. This novel form of p21, which we called p21D, was probably derived from p21 by proteolytic cleavage removing around 10 amino acids from the C-terminus, which results in the loss of the PCNA binding region, the cyclin binding region and part of the nuclear localization signal. p21D was distinct from full length p21 in the respect that they had dierent pattern of nuclear-cytoplasm localization, that no association between p21D with Cdk2 and PCNA was detected, and that a signi®cant portion of p21D was in a monomeric form. Tchou et al. (1996) detected the appearance of a faster migrating form of p21 when Calu-1 cells and A549 cells were treated with the phorbol ester TPA, which arrested these cells in G2/M. This faster migrating form of p21 was not induced in TPA-treated U937 cells, which do not exhibit a TPA-induced G2/M arrest. It is likely that the novel form of p21 observed by Tchou et al. corresponds to the p21D we describe here. There are other known TPA-induced cleavages, such as that of the speci®c proteolytic cleavage of the CSF-1 receptor near its transmembrane segment, resulting in the release of the extracellular ligand-binding domain from the cell and the generation of an intracellular fragment containing the kinase domain (Downing et al., 1989) . However, the rate of TPA-induced p21 cleavage appears to be much faster than that of CSF-1 receptor cleavage. Tchou et al. found that the faster migrating form of p21 is recognized by antibodies raised against the N-terminus but not the C-terminus of p21. The mitotic cyclin-CDK complexes (cyclin A-Cdc2 and cyclin B-Cdc2) bind weakly to p21, although a very small fraction of Cdc2 does associate with p21 in the cell Poon et al., 1996) . It is possible that p21D may play a role in the regulation of Cdc2, but we have not detected any p21D binding to Cdc2 (data not shown).
There is no direct proof that p21D is derived directly from p21. It is possible that p21D is encoded from an alternatively spliced mRNA derived from the p21 gene, but RT ± PCR/Southern analysis of p21 mRNAs by Tchou et al. (1996) argues against this. It has been reported that p21 is phosphorylated on Ser98 and Ser130 (Zhang et al., 1994) , which may cause a change in mobility of p21. However, our own data indicate that phosphorylation of p21 causes a small upward mobility shift on SDS ± PAGE (unpublished data). We also cannot rule out the remote possibility that p21D is a p21-related protein, which is synthesized following very high dose of UV-induced damage and in many transformed cells. This is supported by the fact that we were only able to detect p21D on immunoblots (using many dierent cell lines and several dierent antibodies raised against full length p21), but we were not able to immunoprecipitate p21D directly from cell extracts. But this could also be because when p21 was converted to p21D, the epitopes were masked due to a conformational change or binding to other proteins. More rigorous proof of the origin of p21D requires puri®cation of sucient quantity of p21D to perform C-terminal protein sequencing; this would also indicate the site of proteolytic cleavage. For the purpose of the rest of the discussion we made the assumption that p21D is a degradation product of p21.
If p21D is derived from proteolytic cleavage of p21, an important question is why is p21 speci®cally cleaved into p21D constitutively in many transformed cells and after a very high dose of UV irradiation damage in normal cells? It is conceivable that there is a general increase in protease activity following high dose of UV and transformation. Indeed we found that recombinant p21 was degraded more eciently in extracts of UVirradiated and HeLa cells. However, no distinct degradation products corresponding to p21D was observed (data not shown). It is likely that other eects of UV than DNA damage may be involved in the generation of p21D. The induction of p21D by other kinds of DNA damaging agents like adriamycin was less apparent (for example see Figure 1b ) even when high dosage was used (unpublished observations).
Several cell cycle regulatory proteins like the mitotic cyclins (Glotzer et al., 1991) and Cdc25 (Nefsky and Beach, 1996) , and the p21-related CDK inhibitor p27
Kip1 are degraded by the ubiquitination-proteasome pathway (Pagano et al., 1995) . The fact p21 and p21D are stabilized by the proteasome inhibitor LLnL suggests that p21 and p21D are also degraded by the ubiquitination-proteasome pathway. However, no ubiquitinated form of p21 was observed, nor there is any other evidence to support the hypothesis that p21 is degraded by ubiquitination (Pagano et al., 1995) . Together with the fact that LLnL is not completely speci®c for proteasome, it is possible that p21 is degraded by mechanisms without involving ubiquitination and proteasome (Blagosklonny et al., 1996) . It is conceivable that p21 is converted into p21D by an apoptosis-mediated protease activity, especially after the cells are irradiated with UV. There is no good ICE protease consensus site in p21, and a ICE protease peptide inhibitor did not aect the expression of p21D in irradiated nor transformed cells (unpublished data). But it is possible that other subfamily of apoptosis mediated caspases may be involved in the cleavage of p21. Residues 154 ± 156 are KRR and this sequence could be cleaved by a trypsin-like protease. We do not think this sequence is cleaved in vitro after the cells are lysed since p2LD was still observed when the cells were lysed in boiling SDS-sample buer.
p21D was not found associated with cyclin-Cdk2 in cell extracts, whereas recombinant C-terminal deletion mutants of p21 (deletion up to residue 72) could bind and inhibit cyclin-Cdk2 in vitro with similar ability as full length p21. Moreover, overexpression of Cterminal deletion mutants of p21 in cells could arrest cells in GI. This suggests that the lack of inhibiting activity of p21D is not absolute; vast overexpression of p21 mutants was able to push the equilibrium towards cyclin-CDK inhibition. However, it is likely that under physiological conditions, a C-terminal truncated form of p21, like p21D, is less eective in inhibiting cyclin-CDK and the cell cycle than full length p21. This could partly be due to the dierent localization of p21D in comparison to p21. The C-terminus of p21 binds to PCNA, which forms trimeric ring complexes around DNA strands (Gulbis et al., 1996) . The lack of the PCNA binding domain and the putative nuclear localization sequence in p21D may explain why it is not restricted to the nucleus. However, p21D may be small enough to enter the nucleus passively, and if its anity for cyclin-Cdk2 is high enough it should be retained there simply as a result of being bound to nuclear cyclin-Cdk2. Consistent with this, p21D was found in both the nuclear and cytoplasmic fractions (Figure 4) , and immuno¯uorescence staining of FLAG-tagged p21 transfected HeLa cells showed that the overexpressed p21 was localized exclusively to the nucleus, whereas the C-terminal truncation mutant (CD150) was localized to both the nucleus and the cytoplasm (data not shown). Nevertheless, the lack of the C-terminal second cyclin-binding site, plus the fact that the nuclear localization sequence is compromised may be sucient to explain for the distinct localization of p21D. Another possibility is that transformed cells have an active process to export p21D.
In normal cells, p21 (and PCNA) are associated with various cyclin-CDK complexes, but this interaction is disrupted in transformed cells (Xiong et al., 1993b ); cleavage of p21 described here may be in part responsible for this rearrangement of cyclin-CDK subunits. One important question is whether the degradation of p21 observed in transformed cells is a contributing factor in transformation, or whether it is only a consequence of transformation. Conceptually, it is an intriguing possibility that cleavage and inactivation of p21, which deregulates cyclin-CDK complexes, could be a mechanism that contributes to cellular transformation. The loss of the normal basal level of p21 would decrease the amount of cyclin-CDK required to saturate the total pool of CDK inhibitors, and cyclin-CDK could then be activated earlier in the cell cycle than normal. More importantly, when DNA is damaged, the increased level of p21 may not be sucient to inhibit all the cyclin-CDK because some p21 is degraded into the p21D form. One way to test this is to see whether p21
7/7 cells are more susceptible to transformation, either in terms of a higher frequency of transformation or in requiring fewer events for transformation. The fact that p21 7/7 cells are more susceptible to irradiation-induced DNA damage provides some support to the importance of p21 in guarding against transformation. p21 7/7 mouse embryonic ®broblasts still showed contact inhibition, but they grew to higher saturation density than normal mouse embryonic ®broblasts (Deng et al., 1995) . Entry into the cell cycle is also accelerated during liver regeneration after partial hepatectomy in p21 7/7 mice (JH Albrecht and RYCP, unpublished data). It would be of interest to investigate whether p21 is degraded into p21D in some dierentiated tissues and in cancers. It is known that many protease inhibitors are eective as cancer chemopreventive agents (Troll and Kennedy, 1993) , one possible eect of protease inhibitors may be to prevent the degradation of proteins like p21.
Materials and methods

Cell culture
AG1523 normal human foreskin diploid ®broblasts were obtained from the NIA Aging Cell Repository, Institute for Medical Research (Camden, NJ). KD normal human diploid ®broblasts and a KD-derived chemical carcinogentransformed cell line, HUT12 (Kakunaga, 1978) were gifts from G Orend (Burnham Institute, La Jolla). HeLa (human cervical carcinoma cells), HaCaT (immortalized human keratinocytes), 293 cells (transformed human embryonic kidney cells), HepG2 (human hepatocellular carcinoma cells), and K562 (human chronic myelogenous leukemia cells) cells were obtained from the American Type Culture Collection (Rockville, MD). LAN5 cells (human neuroblastoma cells) were a gift from S Simon (The Salk Institute). HtTA1 cells (HeLa cells stably transfected with pUHD15-1 expressing the tTA tetracycline repressor chimera) (Gossen and Bujard, 1992) were gifts from M Gossen and H Bujard; HtTA1 cells express genes cloned into the pUHD-P1 vector in the absence of tetracycline but not in its presence. p53 7/7 mouse embryonic ®broblasts were a gift from W Eckhart (The Salk Institute).
Cells were grown in Dulbeceo's modi®ed Eagle's medium (DMEM) supplemented with 10% v/v fetal calf serum in a humidi®ed incubator at 378C, in 10% CO 2 . AG1523 and KD cells were used between passage 8 ± 25. Nuclear and cytoplasmic fractionation was performed as described . Cell-free extracts were prepared as described . The protein concentration of cell lysates was measured with bicinchoninic acid protein assay system (Pierce, Rockford, IL) using bovine serum albumin as a standard. Immunoblotting with anti-tubulin was used to con®rm similar amount of proteins were loaded on the gel.
Cells were irradiated with UV essentially as described by Lu and Lane (1993) . Cells were grown to semi-con¯uence in DMEM supplemented with 10% v/v fetal calf serum in a humidi®ed incubator at 378C in 10% CO 2 . The medium was removed and the cells were irradiated with the indicated dose of UV (UV-C) in a Stratalinker UV crosslinker 2400 apparatus (Stratagene). Fresh medium was then added and cells were returned to the incubator. Cells were harvested and cell extracts prepared 12 h after irradiation. DNA damage was also induced by treating cells with 0.2 mg/ml of adriamycin (also called doxorubicin) for 12 h. Proteasome activity was inhibited by treating the cells with 50 mM LuL (N-acetyl-L-leucinyl-L-leucinal L-norleucinal) (also called MG101) (Bachem) for 12 h.
Constructs
GCAGCTCGAGGCCCCGCAC-3' (CD72); 5'-ACCCTCC-TCGAGTGTCTCGGTGACAAA-3' (CD58). The PCR products were cut with NcoI ± XhoI and ligated into NcoI ± XhoI cut pGEX-KG. Subcloning into pUHD-PI (a variant of pUHD10-3 (Gossen and Bujard, 1992) with the FLAG-tag sequence inserted at the N-terminal end of the expressed protein, a gift from KP Lu (Beth Israel Deaconess Medical Center, Harvard Medical School)) was performed by ampli®cation by PCR of the full length p21 or various p21 mutants with a pGEX forward primer and 5'-CATCACCGAAACGCGCGAGGC-3' (a pGEX reverse primer), cut with NcoI, and ligated into NcoI cut and dephosphorylated pUHD-P1. CD20 in pCMX was a gift from H Toyoshima (The Salk Institute).
Transient transfection and FACS analysis
Semi-con¯uent HtTA1 cells (10 cm plates) were transiently transfected with the pUHD-P1 vector, or p21, CD157, or CD150 in pUHD-P1 (20 mg) together with pCMX-CD20 (2 mg) using the calcium phosphate-BES (N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid) method (Ausubel et al., 1991) . After transfection (16 h), fresh medium was added and cells were grown for another 48 h. Cells were trypsinized, washed with PBS, and incubated with anti-CD20 (Leu-16) FITC antibody (Becton Dickinson) according to the manufacturer's instructions. Cells were then ®xed in 70% ethanol and stained with propidium iodide prior to FACS analysis.
Expression and puri®cation of recombinant proteins
Expression of GST-tagged and histidine-tagged proteins in bacteria and puri®cation with GSH-agarose and nickel-NTA agarose chromatography respectively were as described . Thrombin digestion of GST-fusion proteins was as described . Transcription of mRNA in vitro and translation in the mRNA-dependent reticulocyte lysate in the presence of 35 Smethionine was as described (Jackson and Hunt, 1983) .
Histone H1 kinase assay
Immunoprecipitates equilibrated with kinase buer (80 mM Na-b-glycerophosphate pH 7.4, 20 mM EGTA, 15 mM Mg(OAc) 2 and 1 mM DTT) were mixed with 10 ml kinase buer containing 50 mM ATP, 1.25 mCi g-[ 32 P]-ATP, and 1 mg histone H1. The samples were incubated at 238C for 30 min and the reactions were terminated by addition of 30 ml of SDS-sample buer. The samples were subjected to SDS ± PAGE and phosphorylation was detected with a Phosphorimager (Molecular Dynamics).
